Thanks for your level headed analysis. As usual, you are a class act Flendy.
Design freeze, fda, ce approvals should all be a boon to market cap. I'm skeptical they can retain share price growth. It seems only consistent net income growth can bolster sp growth. But who knows optimism could drive sp up. I'm just thinking of conformis...sp should be sky high, the next thing in a huge market but anemic sales have made it a deep discount stock. Just shows how 510k is not necessarily panacea.
News 
Market Data 
Discover 
